Trial intelligence / Profile preview

Interaction of Gabapentin, Duloxetine, and Donepezil in Diabetic Neuropathy

NCT00619983Phase 4Terminated

Sponsor
Wake Forest University
Start
Feb 2008
Primary completion
May 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of donepezil in diabetic neuropathy, chronic low back pain (CLBP), sponsored by Wake Forest University. Started Feb 2008; status: terminated.

02

Drugs

donepezil
03

Conditions

diabetic neuropathychronic low back pain (CLBP)

Beyond the preview

Go deeper on NCT00619983.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00619983.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call